Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Yeap

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|March 10, 2001
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882)K J Pandya, B Y Yeap, L M Weiner, et al.
Bone Marrow Transplantation|September 17, 2008
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphomaR Z Yusuf, B Dey, B Y Yeap, et al.
The Journal of Pathology|January 27, 2007
Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesotheliomaG J Gordon, M Mani, L Mukhopadhyay, et al.
The Pharmacogenomics Journal|March 22, 2007
Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinibG Liu, S Gurubhagavatula, W Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimenM A Shipp, B Y Yeap, D P Harrington, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Cancer|August 15, 1990
Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survivalJ D Licht, L D Bosserman, J W Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2012
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancerA T Shaw, A M Varghese, B J Solomon, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
British Journal of Cancer|July 3, 2008
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsJ P Koivunen, J Kim, J Lee, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|March 10, 2001
Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882)K J Pandya, B Y Yeap, L M Weiner, et al.
Bone Marrow Transplantation|September 17, 2008
Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphomaR Z Yusuf, B Dey, B Y Yeap, et al.
The Journal of Pathology|January 27, 2007
Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesotheliomaG J Gordon, M Mani, L Mukhopadhyay, et al.
The Pharmacogenomics Journal|March 22, 2007
Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinibG Liu, S Gurubhagavatula, W Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimenM A Shipp, B Y Yeap, D P Harrington, et al.
Seminars in Hematology|April 1, 1987
The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphomaG P Canellos, A T Skarin, M M Klatt, et al.
Cancer|August 15, 1990
Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survivalJ D Licht, L D Bosserman, J W Andersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2012
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancerA T Shaw, A M Varghese, B J Solomon, et al.
Bone Marrow Transplantation|November 27, 2007
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantationR L Haspel, G Kao, B Y Yeap, et al.
British Journal of Cancer|July 3, 2008
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsJ P Koivunen, J Kim, J Lee, et al.
Pageof 3